Leaflet PARICALCITOL HEATON 1mcg 1mcgm soft capsules

Product code:
W71461001
Quantity:
7
Indicated for:
hyperparathyroidism
Route of administration:
oral
Substance:
paricalcitol (vitamin D / vitamin D analogue)
ATC
H05BX02 — Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents
Paricalcitol is a vitamin D analog used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It helps regulate calcium and phosphorus levels in the body, reducing excessive secretion of parathyroid hormone (PTH).

The medication is administered intravenously or orally, as directed by your doctor. It is important to monitor calcium, phosphorus, and PTH levels during treatment to prevent complications.

Side effects may include nausea, itching, hypercalcemia, or, in rare cases, severe allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as bone or kidney diseases, to ensure the safe use of paricalcitol.

General data about PARICALCITOL HEATON 1mcg 1mcgm

Substance:
paricalcitol
Date of latest medicines list:
01-12-2025
Product code:
W71461001
Concentration:
1mcgm
Pharmaceutical form:
soft capsules
Quantity:
7
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
GAP S.A. - GRECIA
Holder:
HEATON K.S. - REPUBLICA CEHA
Number:
16285/2025/01
Shelf life:
2 years

Pharmaceutical forms available for paricalcitol

Concentrations available for paricalcitol

  • 10mcg/ml
  • 1mcg
  • 1mcgm
  • 2mcg
  • 2mcg/ml
  • 4mcg
  • 5mcg/ml